CarloBrunoBifulcoMD

Pathology • New Haven, CT

Hematopathology, Molecular Genetics, Anatomic Pathology

Physician

Join to view full profile

Dr. Bifulco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bifulco's full profile

Already have an account?

Office
20 York St
Yale-New Haven Children's Hospital-Ep 2608
New Haven, CT 06510
Phone+1 203-785-3624

Fax+1 203-785-7037

Education & Training

Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1998 - 2000
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 1997
Griffin HospitalInternship, Internal Medicine, 1995 - 1996
University of Milan Faculty of MedicineClass of 1994

Certifications & Licensure

OR State Medical License 2008 - 2025
American Board of Pathology Anatomic Pathology
American Board of Pathology Molecular Genetic Pathology

Publications & Presentations

PubMed

Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System.
Alexa K Dowdell, Ryan C Meng, Ann Vita, Bela Bapat, Douglas Hanes
JCO Oncology Practice. 2024-11-01
1 citations
Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of Ame...
Larissa V Furtado, Carlo Bifulco, Daniel Dolderer, Susan J Hsiao, Benjamin R Kipp
The Journal of Molecular Diagnostics. 2024-08-01
17 citations
A whole-slide foundation model for digital pathology from real-world data.
Hanwen Xu, Naoto Usuyama, Jaspreet Bagga, Sheng Zhang, Rajesh Rao
Nature. 2024-06-01

Abstracts/Posters

Flotetuzumab (FLZ), an Investigational CD123 x CD3 Bispecific Dart¬ Protein-Induced Clustering of CD3+ T Cells and CD123+ AML Cells in Bone Marrow Biopsies Is Associat...
Carlo B Bifulco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced CancerNovember 13th, 2024
Blood Tests That Can Detect Cancer Are About to Hit the Market. But Experts Are Still Waiting to See if They Can Upend Deadly DiseaseOctober 20th, 2021
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for AllAugust 18th, 2021
Join now to see all